LFG
ANIP icon

LifePlan Financial Group’s ANI Pharmaceuticals ANIP Stock Holding History

LifePlan Financial Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1
Closed – – 220
2013
Q2 		$0 Buy
+1
New +$7 ﹤0.01% 197

Other funds holding ANIP

HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICOA
Investment Centers of America Bismarck, North Dakota $712K AUM 15.54% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

LifePlan Financial Group's ANIP Position: Q3 2013 in Review

LifePlan Financial Group sold out of ANI Pharmaceuticals (ANIP) in Q3 2013, closing a stake of 1 share.

LifePlan Financial Group first reported a position in ANIP in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 28 funds tracked by Wall St. Rank hold ANIP as of Q3 2013.

  • LifePlan Financial Group reported no remaining ANI Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • LifePlan Financial Group sold 1 ANI Pharmaceuticals share in Q3 2013.
  • LifePlan Financial Group first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • LifePlan Financial Group's ANI Pharmaceuticals position peaked at $0 in Q2 2013.
  • 28 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2013.

Based on LifePlan Financial Group's 13F filing for Q3 2013, filed 13 Nov 2013.